Silverback Asset Management’s Standard BioTools LAB Stock Holding History

Silverback Asset Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,300	Closed	-$2.51K	–	71
2024 Q3	$2.51K	Sell	1,300 -29,958	-96%	-$58.7K	﹤0.01%	81
2024 Q2	$55.3K	Sell	31,258 -93,742	-75%	-$229K	0.01%	78
2024 Q1	$339K	Hold	125,000	–	–	0.05%	71
2023 Q4	$276K	Sell	125,000 -175,000	-58%	-$374K	0.04%	76
2023 Q3	$870K	Sell	300,000 -150,000	-33%	-$392K	0.12%	74
2023 Q2	$869K	Buy	450,000 +50,000	+13%	+$98.7K	0.12%	74
2023 Q1	$780K	Buy	+400,000	New	+$790K	0.11%	79
2022 Q3	–	Sell	-200,000	Closed	-$320K	–	136
2022 Q2	$320K	Hold	200,000	–	–	0.05%	72
2022 Q1	$718K	Hold	200,000	–	–	0.1%	63
2021 Q4	$784K	Sell	200,000 -85,744	-30%	-$401K	0.09%	56
2021 Q3	$1.88M	Buy	+285,744	New	+$1.88M	0.28%	52
2020 Q3	–	Sell	-69,769	Closed	-$280K	–	54
2020 Q2	$280K	Sell	69,769 -304,700	-81%	-$1.06M	0.07%	49
2020 Q1	$951K	Buy	374,469 +215,771	+136%	+$709K	0.2%	44
2019 Q4	$552K	Buy	+158,698	New	+$558K	0.08%	41
2018 Q2	–	Sell	-19,898	Closed	-$116K	–	48
2018 Q1	$116K	Sell	19,898 -145,102	-88%	-$953K	0.02%	48
2017 Q4	$972K	Buy	165,000 +30,000	+22%	+$164K	0.18%	46
2017 Q3	$680K	Buy	+135,000	New	+$567K	0.11%	48

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Silverback Asset Management's LAB Position: Q4 2024 in Review

Silverback Asset Management sold out of Standard BioTools (LAB) in Q4 2024, closing a stake of 1,300 shares — an estimated $2.51K sold.

Silverback Asset Management first reported a position in LAB in Q3 2017 and held it in 17 quarters. The position peaked at $1.88M in Q3 2021. 142 funds tracked by Wall St. Rank hold LAB as of Q4 2024.

Silverback Asset Management reported no remaining Standard BioTools position as of Q4 2024 after selling out during the quarter.
Silverback Asset Management sold 1,300 Standard BioTools shares in Q4 2024, an estimated $2.51K.
Silverback Asset Management first reported a position in Standard BioTools in Q3 2017 and held it in 17 quarters.
Silverback Asset Management's Standard BioTools position peaked at $1.88M in Q3 2021.
142 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2024.

Based on Silverback Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.